Page 1 of 43
NSG 124 EXAM 1 – HERZING PHARMACOLOGY NCLEX
STYLE 2026/2027 COMPLETE CURRENT TESTING
QUESTIONS AND CORRECT ANSWERS WITH DETAILED
RATIONALES.
PHARMACOLOGY
Prepare for NSG 124 Exam 1 with this focused Pharmacology NCLEX-style study
resource from Herzing University. It is designed to reinforce essential pharmacology
concepts, medication classifications, administration principles, adverse effects,
safety considerations, and nursing interventions. The NCLEX-style format helps you
practice applying pharmacology knowledge to clinical scenarios while strengthening
prioritization and critical-thinking skills. Use this resource alongside your coursework
to review key concepts and build confidence for the exam.
MULTIPLE CHOICE.
Module 1: Pharmacokinetics & Pharmacodynamics (Questions 1–20)
1. The nurse is teaching a patient about medication absorption. Which
statement best describes the process of absorption?
A. The movement of a drug from the bloodstream to the site of action
B. The movement of a drug from its site of administration into the bloodstream
C. The chemical alteration of a drug to a more water-soluble form
D. The elimination of a drug from the body through the kidneys
Answer: B
Rationale: Absorption is the process by which a drug moves from its site
of administration into the bloodstream. Distribution (A) is the transport of
drugs from the bloodstream to tissues. Metabolism (C) is chemical
alteration. Excretion (D) is elimination from the body.
2. A patient asks the nurse why his oral medication is not working as
quickly as the IV medication he received in the hospital. Which response
by the nurse is most accurate?
A. "IV medications are stronger than oral medications."
B. "Oral medications must be absorbed through the gastrointestinal tract
, Page 2 of 43
before entering the bloodstream, which takes longer."
C. "Your body has developed a tolerance to the oral medication."
D. "The oral medication is probably expired."
Answer: B
Rationale: Oral medications must undergo absorption through the GI tract
before reaching the bloodstream, which delays their onset compared to
IV medications. IV administration bypasses absorption entirely, providing
100% bioavailability. IV medications are not inherently "stronger," and
tolerance or expiration is not the primary reason for the difference.
3. A patient with renal impairment is prescribed a medication that is
primarily excreted by the kidneys. The nurse expects:
A. The medication will be more effective
B. The medication will have a shorter duration of action
C. The medication may accumulate and cause toxicity
D. The medication will be metabolized faster
Answer: C
Rationale: When a drug is primarily excreted by the kidneys and the
patient has renal impairment, drug elimination is slowed. This can lead to
drug accumulation and increased risk of toxicity. Renal impairment does
not increase drug effectiveness, shorten duration, or accelerate
metabolism.
4. Which pharmacokinetic process involves the movement of a drug from
the bloodstream into tissues and organs?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: B
Rationale: Distribution is the movement of a drug from the bloodstream
into tissues and organs. Absorption is movement from the site of
administration into the blood. Metabolism is the chemical alteration of
the drug. Excretion is the removal of the drug from the body.
, Page 3 of 43
5. A nurse is calculating a loading dose for a patient. What is the primary
purpose of a loading dose?
A. To maintain steady-state plasma levels
B. To rapidly achieve therapeutic drug levels
C. To reduce the risk of adverse effects
D. To prolong the half-life of the drug
Answer: B
Rationale: A loading dose is given to rapidly achieve therapeutic plasma
concentrations, especially when the time to reach steady state is too long
for the clinical situation. Maintenance doses are used to maintain steady-
state levels. A loading dose does not reduce adverse effects or prolong
half-life.
6. Which statement best describes the concept of a drug's half-life (t½)?
A. The time required for the drug to be completely eliminated from the body
B. The time required for the plasma concentration of the drug to decrease by
50%
C. The time required for the drug to reach its maximum effect
D. The time required for the drug to be absorbed
Answer: B
Rationale: The half-life is the time required for the plasma concentration
of a drug to decrease by 50%. It takes approximately 4–5 half-lives to
reach steady state or to eliminate most of the drug from the body.
Complete elimination does not occur in one half-life.
7. A patient is taking a drug that is highly protein-bound. Which situation
could increase the free (active) fraction of the drug and potentially cause
toxicity?
A. Increased albumin levels
B. Decreased albumin levels
C. Increased renal excretion
D. Increased hepatic metabolism
Answer: B
Rationale: Decreased albumin levels (e.g., in malnutrition, liver disease,
or nephrotic syndrome) reduce the number of binding sites, increasing
, Page 4 of 43
the free (active) fraction of highly protein-bound drugs, which can lead to
toxicity. Increased albumin would decrease the free fraction. Renal
excretion and hepatic metabolism affect elimination, not protein binding.
8. Which of the following best describes a drug's therapeutic index?
A. The ratio of the toxic dose to the therapeutic dose
B. The ratio of the effective dose to the lethal dose
C. The time required for the drug to reach peak effect
D. The percentage of the drug that is absorbed
Answer: A
Rationale: The therapeutic index is the ratio of the toxic dose to the
therapeutic dose. A narrow therapeutic index means there is a small
margin between therapeutic and toxic doses, requiring careful
monitoring. The effective-to-lethal dose ratio is the LD50/ED50 ratio,
which is a related but distinct concept.
9. A patient is prescribed a drug that is a potent enzyme inducer. Which
effect would this have on another drug metabolized by the same enzyme?
A. Increased plasma levels of the second drug
B. Decreased plasma levels of the second drug
C. No effect on the second drug
D. Increased toxicity of the second drug
Answer: B
Rationale: Enzyme inducers increase the activity of metabolic enzymes,
leading to faster metabolism and decreased plasma levels of drugs
metabolized by the same enzyme. This can reduce the therapeutic effect
of the second drug. Enzyme inhibitors would increase plasma levels.
10. Which receptor type is directly coupled to ion channels and mediates
rapid responses?
A. G protein-coupled receptors
B. Ligand-gated ion channels
C. Nuclear receptors
D. Tyrosine kinase receptors
NSG 124 EXAM 1 – HERZING PHARMACOLOGY NCLEX
STYLE 2026/2027 COMPLETE CURRENT TESTING
QUESTIONS AND CORRECT ANSWERS WITH DETAILED
RATIONALES.
PHARMACOLOGY
Prepare for NSG 124 Exam 1 with this focused Pharmacology NCLEX-style study
resource from Herzing University. It is designed to reinforce essential pharmacology
concepts, medication classifications, administration principles, adverse effects,
safety considerations, and nursing interventions. The NCLEX-style format helps you
practice applying pharmacology knowledge to clinical scenarios while strengthening
prioritization and critical-thinking skills. Use this resource alongside your coursework
to review key concepts and build confidence for the exam.
MULTIPLE CHOICE.
Module 1: Pharmacokinetics & Pharmacodynamics (Questions 1–20)
1. The nurse is teaching a patient about medication absorption. Which
statement best describes the process of absorption?
A. The movement of a drug from the bloodstream to the site of action
B. The movement of a drug from its site of administration into the bloodstream
C. The chemical alteration of a drug to a more water-soluble form
D. The elimination of a drug from the body through the kidneys
Answer: B
Rationale: Absorption is the process by which a drug moves from its site
of administration into the bloodstream. Distribution (A) is the transport of
drugs from the bloodstream to tissues. Metabolism (C) is chemical
alteration. Excretion (D) is elimination from the body.
2. A patient asks the nurse why his oral medication is not working as
quickly as the IV medication he received in the hospital. Which response
by the nurse is most accurate?
A. "IV medications are stronger than oral medications."
B. "Oral medications must be absorbed through the gastrointestinal tract
, Page 2 of 43
before entering the bloodstream, which takes longer."
C. "Your body has developed a tolerance to the oral medication."
D. "The oral medication is probably expired."
Answer: B
Rationale: Oral medications must undergo absorption through the GI tract
before reaching the bloodstream, which delays their onset compared to
IV medications. IV administration bypasses absorption entirely, providing
100% bioavailability. IV medications are not inherently "stronger," and
tolerance or expiration is not the primary reason for the difference.
3. A patient with renal impairment is prescribed a medication that is
primarily excreted by the kidneys. The nurse expects:
A. The medication will be more effective
B. The medication will have a shorter duration of action
C. The medication may accumulate and cause toxicity
D. The medication will be metabolized faster
Answer: C
Rationale: When a drug is primarily excreted by the kidneys and the
patient has renal impairment, drug elimination is slowed. This can lead to
drug accumulation and increased risk of toxicity. Renal impairment does
not increase drug effectiveness, shorten duration, or accelerate
metabolism.
4. Which pharmacokinetic process involves the movement of a drug from
the bloodstream into tissues and organs?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: B
Rationale: Distribution is the movement of a drug from the bloodstream
into tissues and organs. Absorption is movement from the site of
administration into the blood. Metabolism is the chemical alteration of
the drug. Excretion is the removal of the drug from the body.
, Page 3 of 43
5. A nurse is calculating a loading dose for a patient. What is the primary
purpose of a loading dose?
A. To maintain steady-state plasma levels
B. To rapidly achieve therapeutic drug levels
C. To reduce the risk of adverse effects
D. To prolong the half-life of the drug
Answer: B
Rationale: A loading dose is given to rapidly achieve therapeutic plasma
concentrations, especially when the time to reach steady state is too long
for the clinical situation. Maintenance doses are used to maintain steady-
state levels. A loading dose does not reduce adverse effects or prolong
half-life.
6. Which statement best describes the concept of a drug's half-life (t½)?
A. The time required for the drug to be completely eliminated from the body
B. The time required for the plasma concentration of the drug to decrease by
50%
C. The time required for the drug to reach its maximum effect
D. The time required for the drug to be absorbed
Answer: B
Rationale: The half-life is the time required for the plasma concentration
of a drug to decrease by 50%. It takes approximately 4–5 half-lives to
reach steady state or to eliminate most of the drug from the body.
Complete elimination does not occur in one half-life.
7. A patient is taking a drug that is highly protein-bound. Which situation
could increase the free (active) fraction of the drug and potentially cause
toxicity?
A. Increased albumin levels
B. Decreased albumin levels
C. Increased renal excretion
D. Increased hepatic metabolism
Answer: B
Rationale: Decreased albumin levels (e.g., in malnutrition, liver disease,
or nephrotic syndrome) reduce the number of binding sites, increasing
, Page 4 of 43
the free (active) fraction of highly protein-bound drugs, which can lead to
toxicity. Increased albumin would decrease the free fraction. Renal
excretion and hepatic metabolism affect elimination, not protein binding.
8. Which of the following best describes a drug's therapeutic index?
A. The ratio of the toxic dose to the therapeutic dose
B. The ratio of the effective dose to the lethal dose
C. The time required for the drug to reach peak effect
D. The percentage of the drug that is absorbed
Answer: A
Rationale: The therapeutic index is the ratio of the toxic dose to the
therapeutic dose. A narrow therapeutic index means there is a small
margin between therapeutic and toxic doses, requiring careful
monitoring. The effective-to-lethal dose ratio is the LD50/ED50 ratio,
which is a related but distinct concept.
9. A patient is prescribed a drug that is a potent enzyme inducer. Which
effect would this have on another drug metabolized by the same enzyme?
A. Increased plasma levels of the second drug
B. Decreased plasma levels of the second drug
C. No effect on the second drug
D. Increased toxicity of the second drug
Answer: B
Rationale: Enzyme inducers increase the activity of metabolic enzymes,
leading to faster metabolism and decreased plasma levels of drugs
metabolized by the same enzyme. This can reduce the therapeutic effect
of the second drug. Enzyme inhibitors would increase plasma levels.
10. Which receptor type is directly coupled to ion channels and mediates
rapid responses?
A. G protein-coupled receptors
B. Ligand-gated ion channels
C. Nuclear receptors
D. Tyrosine kinase receptors
